Next Article in Journal
Genetic Aspects of Tooth Agenesis
Previous Article in Journal
Genome-Wide Identification of the Polygalacturonase Gene Family and Its Potential Association with Abscission Zone in Capsicum annuum L.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Genetic Determinants of Colonic Diverticulosis—A Systematic Review

Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Genes 2025, 16(5), 581; https://doi.org/10.3390/genes16050581
Submission received: 16 April 2025 / Revised: 11 May 2025 / Accepted: 14 May 2025 / Published: 15 May 2025
(This article belongs to the Section Human Genomics and Genetic Diseases)

Abstract

:
Background: Colonic diverticulosis is a common condition, particularly in the elderly population. While dietary habits, obesity, smoking, and physical inactivity contribute to its pathogenesis, emerging evidence highlights a genetic predisposition affecting extracellular matrix (ECM) remodeling, inflammation, and connective tissue integrity. The aim of this systematic review was to summarize genetic determinants of colonic diverticulosis. Methods: The PubMed® database was searched for original studies in humans. The inclusion criteria were named genetic factor and confirmed diverticulosis. Patients with diverticulitis and diverticular diseases were excluded from this review. Results: Out of 137 publications, 10 articles met the inclusion criteria: six large association studies (GWAS) and four cross-sectional studies. The genes regulating ECM turnover, including TIMP1, MMP3, and MMP9, are involved in diverticulosis development. The TIMP1 (rs4898) T allele has been associated with increased susceptibility, potentially due to its role in ECM remodeling. Similarly, MMP3 (rs3025058) and MMP9 (rs3918242) polymorphisms contribute to altered collagen degradation. The COL3A1 (rs3134646) variant coding modified collagen type III may promote diverticular formation. Other genes, such as ARHGAP15 (rs4662344, rs6736741), affect cytoskeletal dynamics. Identified in GWAS studies, gene candidates may be grouped into blood group and immune system-related genes (ABO, HLA-DQA1, HLA-H, OAS1, TNFSF13, FADD), extracellular matrix and connective tissue genes (COL6A1, COLQ, EFEMP1, ELN, HAS2, TIMP2), signaling and cell communication (BMPR1B, WNT4, RHOU, PHGR1, PCSK5), nervous system and neurodevelopment (BDNF, CACNB2, GPR158, SIRT1, SCAPER, TRPS1), metabolism and transporters (SLC25A28, SLC35F3, RBKS, PPP1R14A, PPP1R16B), lipids and cholesterol (LDAH, LYPLAL1, STARD13), transcription and gene regulation (ZBTB4, UBTF, TNRC6B), apoptosis (FADD, PIAS1), and poorly characterized genes (C1TNF7, ENSG00000224849, ENSG00000251283, LINC01082, DISP2, SNX24, THEM4, UBL4B, UNC50, WDR70, SREK1IP1). Conclusions: There are a number of gene variants that probably predispose to colonic diverticulosis. Detailed characterization of the multigene background of diverticulosis will enable appropriate therapeutic or preventive interventions in the future.

1. Introduction

The prevalence of colonic diverticulosis varies in populations around the globe. It is generally recognized that diverticulosis prevalence is higher in the elderly population. In Eastern populations, colonic diverticulosis prevalence was estimated to be 1.97%, and in 85.3% of cases, it was right-sided [1], whereas in Western populations, it is estimated to affect as much as 60% of patients over 60 years of age [2]. In a European study, colonic diverticula were found in 29.6% of adults during colonoscopy, with equal prevalence in both sexes [3]. While often asymptomatic, diverticulosis can progress to symptomatic diverticular disease or diverticulitis, causing significant morbidity and healthcare burden [1,2].
The pathogenesis of colonic diverticulosis is multifactorial, involving an interplay between increased colonic pressure, structural weakness of the colon wall, altered gut microbiota, inflammation, and age-related changes [4,5]. One of the primary factors contributing to the formation of diverticula is high intraluminal pressure. The colon’s muscular wall generates significant pressure during peristalsis to move the stool. In a low-fiber diet, containing usually red meat and processed food, stool tends to be harder and more difficult to pass, thus stimulating prolonged periods of increased pressure in the colon. This pressure can eventually force the mucosal and submucosal layers of the colon to herniate through weak points in the muscular layer, resulting in the formation of diverticula [4]. Recent research has highlighted the significance of dietary habits, stressing the protective effect of fiber-rich diets in preventing both the onset and progression of diverticular disease [6]. Beyond dietary factors, emerging evidence suggests a potential link between lifestyle and diverticulosis. Sedentary lifestyle and obesity have been recognized as independent risk factors for diverticular disease [7]. The mechanisms behind these associations are still under active investigation, with hypotheses spanning from the modulation of gut microbiota to systemic inflammation. The formation of diverticula is also influenced by structural weakness in the colonic wall. According to Hansen and Stock’s classification of diverticular disease, asymptomatic diverticulosis (stage 0) may progress to uncomplicated diverticulitis (stage I), and further to complicated diverticulitis (stage II) with presence, of phlegmon, abscess or sealed or free perforation, and finally to chronic recurrent diverticulitis (stage III) [8]. Similarly, stages of diverticulosis progression may be identified. The muscular layer of the colon, particularly the circular muscle fibers, may exhibit defects or thinning that predispose to herniation under high pressure. The wall of the colon is structurally weak at points, where blood vessels (vasa recta) penetrate the muscular layer to supply the blood (stage 1). These vessels create areas of inherent weakness, which can become the site of diverticulum formation under increased pressure (stage 2). The role of connective tissue in the pathogenesis of diverticulosis is crucial. Alterations in the production or breakdown of collagen and elastin fibers within the muscular layer of the colon can compromise the structural integrity and elasticity of the colonic wall, increasing its susceptibility to herniation under mechanical stress [9,10]. Some genetic factors may predispose individuals to these connective tissue alterations, leading to an increased risk of diverticular formation. Genetic factors involved in extracellular matrix (ECM) remodeling, inflammation, and connective tissue integrity are thought to modulate susceptibility. Several studies have shown that individuals with first-degree relatives affected by diverticulosis are at a higher risk, and certain gene polymorphisms have been linked to the condition [2,11].
The aim of this review was to systematize the available knowledge about genetic risk factors of colonic diverticulosis.

2. Methods and Findings

2.1. Criteria for Considering Studies for This Review

Exclusively original studies in humans were searched. The included studies were required to assess patients with diverticulosis and name the identified genetic factor (e.g., polymorphism, mutation, genetic variant). The present systematic review included all GWAS studies and studies with named SNPs. The studies on diverticulitis and diverticular disease were excluded. The genetic factors that contribute to the formation of diverticula may differ from those that lead to symptomatic uncomplicated diverticular disease or diverticulitis. Each of these conditions involves a distinct anatomical and pathological process, which is not clearly distinguished in the ICD-10 classification. Additionally, clinicians often use the terms “diverticulosis” and “diverticular disease” interchangeably. For this reason, such studies were excluded, as they conflate the risk factors for diverticula formation with those for diverticulitis—factors that are also shared by other infection-based diseases.

2.2. Search Strategy

Two independent reviewers (PN and AP) conducted a search in the PubMed® database (National Library of Medicine, Bethesda, MD, USA) following a predefined research strategy. The following terms were searched in all fields in the query box: ‘diverticulosis’, ‘colon’, and ‘genetic’. Given the limited number of studies, no restrictions were applied regarding publication date or language. This review includes studies published and accessible up until the end of April 2025. There were no disagreements between the reviewers regarding study inclusion, and all reviewers unanimously approved the final selection of articles. The items marked as review articles by the PubMed® database were automatically recognized as illegible for this review. Data were collected independently by all reviewers manually. The searched outcomes were named genetic variant, risk allele, number of participants, population (ethnicity), mean (or median) age, sex, effect measured with odds ratio (OR) (if available), method of genotyping, possible SNP’s in silico effect. This manuscript was prepared in accordance with the PRISMA guidelines [12].

2.3. Research Results

In total, 10 studies meeting the inclusion criteria for this review were found: 6 large association studies based on GWAS search strategy and 4 cross-sectional studies. The PRISMA flowchart for this review is provided in Supplementary Figure S1. For better visualization, this review was divided into sections separately discussing genome-wide association search strategy studies’ results, the role of extracellular matrix, cytoskeletal dynamics genes and proinflammatory cytokines. Due to the heterogeneity of the studies, their construction, results and collected data, it was not possible to conduct a meta-analysis. The summary of the search results and progression stages of diverticula formation is shown Figure 1. The summary and comparison of selected studies on genetic predisposition to colonic diverticulosis is shown in Table 1.

2.3.1. Genome-Wide Association Search Strategy

The whole-genome sequencing (WGS) method allows researchers to identify millions of sequence variants in the human genome. With the beginning of the post genome-wide association studies (GWAS) era, only ARHGAP15, FAM155A, and COLQ were linked with colonic diverticula and diverticulitis [13]. Maguire et al., in a large association study based on a genome-wide search strategy for possible loci associated with colonic diverticulosis, discovered another 42 possible genetic variants, 39 of which were newly identified [14]. Genes identified in Maguire et al.’s study are involved in immune function, extracellular matrix turnover, cell adhesion, membrane transport, and intestinal motility. A phenome-wide association study of these 42 variants suggests a shared genetic background for diverticular disease, obesity, and hernias. Schafmayer et al. discovered 12 novel loci connected with diverticular disease or diverticulitis indicating neuromuscular, connective tissue dysfunction, and epithelial disease mechanisms [15].
The recent transcriptomic study by Seo et al. on colonic specimens identified 38 genes with differing expression levels and 17 genes with altered transcript usage associated with diverticulosis, suggesting that tissue remodeling plays a key role in the formation of diverticula [16]. The formation of diverticula was primarily linked to stromal and epithelial cells in the colon, including endothelial cells, myofibroblasts, fibroblasts, goblet cells, tuft cells, enterocytes, neurons, and glial cells. Seo et al.’s study highlighted five genes CCN3, CRISPLD2, ENTPD7, PHGR1, and TNFSF13 as having potential causal effects on diverticulosis. Notably, ENTPD7 was found to be upregulated in individuals with diverticulosis [16]. Additionally, the grade of diverticulosis was associated with genetic susceptibility to diverticulitis. Seo et al.’s study suggested that tissue remodeling is a key process in the development of diverticula, and individuals with a higher genetic predisposition to diverticulitis tend to have a greater number of diverticula observed during colonoscopy [16].
Another GWAS-based study on a Korean population of patients with right-sided diverticulosis identified another nine new loci possibly correlated with colonic diverticula formation [17]. Choe et al.’s study pointed at genetic variants in wingless-type MMTV integration site family member 4 (WNT4) and Ras homolog family member U (RHOU), and (OAS) 1/3 genes [17,18]. WNT4 was associated with vascular smooth muscle cell proliferation [19]. The RHOU mediates the WNT signaling pathway, which regulates cell morphology, cytoskeletal organization and cell proliferation [20]. The OAS family of proteins is induced by interferon and is associated with the antiviral and apoptotic responses [21]. Choe et al.’s study may indicate that right-sided diverticulosis may be associated with the regulation of vessels’ formation and inflammation [22].

2.3.2. Role of Extracellular Matrix (ECM)

Connective tissue dysfunction contributes to remodeling the colonic mucosa and submucosa into more susceptible to herniation. Alterations in collagen composition notably impact the mechanical strength of connective tissue in individuals with diverticulosis and chronic inflammation [10]. Additionally, collagen fibrils in the left colon tend to decrease in size and become more densely packed as individuals age, especially within the diverticula of the colon [9].

Tissue Inhibitors of Metalloproteinases (TIMPs)

Tissue inhibitors of metalloproteinases (TIMPs) regulate the activity of matrix metalloproteinases (MMPs), which are involved in the degradation of ECM proteins. TIMP1 plays a crucial role in maintaining the balance of ECM turnover by inhibiting MMPs that degrade collagen and other structural components. Increased expression of TIMP1 may impair ECM remodeling, potentially contributing to the formation of weak spots in the colonic wall, predisposing individuals to diverticula formation.
TIMP1 expression is elevated in colon diverticula as well as in colorectal cancer [23]. Studies demonstrated that in the colonic mucosa and submucosa of patients with complicated diverticulosis, there is an increase in mRNA of TIMP1 and TIMP2 compared to healthy subjects [24]. Moreover, the levels of TIMP1 and TIMP2 mRNA are elevated in the colonic muscular layer in patients with diverticulosis, which suggests an association of TIMP expression alteration with diverticula formation [24]. The TIMP1 variant 372 T/C (rs4898) is a single-nucleotide polymorphism (SNP) caused by the substitution of thymine with cytosine at position +372, leading to a silent mutation in exon 5 of the TIMP1 gene. The C allele of TIMP1 rs4898 is associated with arterial hypertension in Malaysian males [25], while the T allele is linked to higher serum TIMP1 levels and increased mortality in individuals with sepsis [26,27].
In male patients with diverticulosis, the allele T of TIMP1 (rs4898) was more prevalent than in healthy controls [28]. The TIMP1 rs4898 T allele has been associated with higher TIMP1 concentrations in serum [29], and this allele appears to be more prevalent in individuals with diverticulosis [29]. Additionally, TIMP1 expression is elevated in the colonic mucosa of patients with diverticulitis, suggesting that TIMP1 might also play a role in the inflammatory process that complicates diverticulosis. TIMP1 is mostly responsible for inhibiting proMMP9 [30]. In vivo, MMP9 activity is critical in remodeling components of the ECM, including collagen IV and laminin in the basement membrane [31]. It was shown that TIMP1 serum concentration was elevated in individuals with rs4898 allele T in TIMP1 [26]. An increase in the TIMP1 level may interplay with proMMP9 levels, which plays a crucial role in ECM breakdown and may predispose individuals with rs4898 allele T in TIMP1 to diverticulosis. Moreover, TIMP1, MMP1 and MMP2 concentrations in colon were higher in tissue samples with diverticula compared to not-affected tissue [32]. This leads to the conclusion that rs4898 allele T TIMP1 may predispose males to diverticulosis. Moreover, TIMP2 rs1973232 was also identified in GWAS-based analysis to be linked with diverticular disease [15].

Matrix Metalloproteinases (MMPs)

Matrix metalloproteinases (MMPs) are a family of zinc-dependent enzymes that play a crucial role in the breakdown of ECM components. Among the MMP family, MMP3, MMP9, and MMP12 are particularly relevant to the pathogenesis of diverticulosis. These enzymes are responsible for the degradation of collagen, elastin, and other ECM proteins, which contribute to the structural integrity of the colonic wall [14].
MMP3, known as stromelysin, is produced by fibroblasts and myofibroblasts and is capable of degrading various ECM components, including type IV collagen, laminin, and proteoglycans. The MMP3 (rs3025058) 5A/5A genotype was linked to the prevalence of diverticulosis [29]. The 6A allele of this polymorphism has been shown to have reduced transcriptional activity, which could affect the balance of ECM degradation in the colon [29].
MMP9, also known as neutrophil gelatinase, is involved in the breakdown of elastin and collagen type IV. It is produced by various cell types, including neutrophils and fibroblasts, and its activity is tightly regulated by TIMPs. The MMP9 gene contains a polymorphism, rs3918242, which has been linked to diverticulosis. The presence of the T allele of this polymorphism may enhance the activity of MMP9, contributing to increased ECM remodeling in the colon [14]. The allele T of MMP9 (rs3918242) was notably more common in individuals with diverticulosis compared to the healthy control group [29].
MMP12, another important member of the MMP family, is primarily produced by macrophages and is involved in the degradation of elastin. Although MMP12 plays a role in ECM remodeling, its involvement in diverticulosis is considered less significant compared to MMP3 and MMP9 [28,29].

Collagen and Connective Tissue Integrity (COL)

Collagen is a major component of the ECM, providing structural support to tissues. Type III collagen, encoded by the COL3A1 gene, is particularly important in tissues subjected to mechanical stress, including the colon. This gene in chromosome 2 encodes for collagen type 3 α 1 chain. Variations in the COL3A1 gene have been associated with an increased susceptibility to diverticulosis [33]. The COL3A1 polymorphism, rs3134646, has been shown to be more frequent in patients with diverticulosis compared to healthy controls [33]. This variant may result in transcripts in regulatory regions possibly playing the role of enhancer. COL3A1 (rs3134646) was also linked to gastroesophageal reflux disease, and hiatal hernia [33,34]. The authors’ own research confirmed that allele C of COL3A1 (rs3134646) may be related to diverticulosis, as this variant was more frequent in individuals with colonic diverticulosis [35]. This genetic variant may influence collagen synthesis and crosslinking, affecting the colon’s mechanical properties and predisposing patients to diverticula formation [36]. In individuals affected with colonic diverticulosis, collagen synthesis is increased and collagen crosslinking is altered [36]. These changes contribute to the mechanical instability of the colonic wall, making it more prone to the formation of diverticula. Also important, collagen remodeling is regulated by MMPs and TIMPs, linking genetic factors involved in ECM turnover to the pathogenesis of diverticulosis [14,34].

2.3.3. Cytoskeletal Dynamics Genes (ARHGAP15)

ARHGAP15, Rho GTPase activating protein 15, a protein encoded by the ARHGAP15 gene in chromosome 2, plays a key role in regulating actin dynamics and cell movement, migration, and adhesion. Overexpression of ARHGAP15 causes an increase in actin stress fibers and cell contraction. This gene contains a variant known as rs4662344, which has been linked to diverticulosis [13]. Moreover, another variant in this gene was identified in one of the GWAS-based studies, namely rs6736741, to be linked with diverticulosis [37]. It contributes to cell adhesion and cytoskeletal organization, both crucial for preserving the integrity of the colonic lining. Changes in ARHGAP15 expression may influence how cells respond to mechanical stress, potentially leading to the formation of diverticula [38]. Research indicates that the T allele of this polymorphism is associated with a higher risk of diverticulosis, suggesting that ARHGAP15 may impact susceptibility to colonic diverticula by affecting extracellular matrix remodeling and inflammation [13,35,39].

2.3.4. Proinflammatory Cytokines (IL, TNF)

The IL1A gene, located on chromosome 2, encodes interleukin-1 α. The T allele of the IL1A variant rs1800587 (C-889T) has been linked to central obesity and metabolic syndrome in individuals with coronary heart disease, as well as an increased risk of intervertebral disc disease [40,41]. Since this allele is associated with obesity—a known risk factor for colonic diverticula formation—it was considered a candidate for analysis. However, in the authors’ own research, there were no significant differences in allele distribution for this variant, possibly due to the relatively low prevalence of obesity in the studied population [35].
The TNFSF15 gene, located on chromosome 9, encodes tumor necrosis factor superfamily member 15, a key regulator of immune function and inflammation. It is involved in both normal immune responses and the development of inflammatory diseases. The TNFSF15 variant rs7848647 has been linked to inflammatory bowel diseases, irritable bowel syndrome, and diverticulitis [42,43,44,45,46]. However, previous studies do not show its link to diverticulosis itself [35].
It seems that genes encoding proinflammatory cytokines are more likely to be linked to diverticulitis than diverticulosis.
Table 1. Summary and comparison of selected studies on genetic predisposition to colonic diverticulosis.
Table 1. Summary and comparison of selected studies on genetic predisposition to colonic diverticulosis.
StudyGeneRisk AllelePopulationAgeEthnicityMethodDICA ScoreORSNP’s Effect *Annotations
Nehring et al. (2025) [35]COL3A1 rs3134646
ARHGAP15 rs4662344
C
T
134 cases;
189 controls
Mean 65.31 ± 13.31 vs. 62.80 ± 11.81PolesRT-PCR11.90
3.44
Not found
Not found
Both sexes
Seo et al. (2024) [16]JOSD1
ENTPD7
SREK1IP1
TNSF13
SIRT1
AP3M1
PHGR1
CRISPLD2
CCN3
HLA-H
LDAH
THEM4
N/A172 cases;
232 controls
Mean 55.7 ± 7.30 vs. 53.5 ± 6.24Self-reported:
80% white
20% black
Transcriptomics,
GWAS, cis-eQTL
61%
distal colon, 35% distal and proximal
colon, 4% proximal colon
N/ABoth sexes
Nehring et al. (2023) [29]MMP9 rs3918242
MMP3 rs3025058
T
5A/5A
59 cases;
75 controls
Mean
64.5 ± 12.6 vs. 60.9 ± 12.6
PolesRT-PCR12.62
2.25
Not found
Not found
Both sexes
Joo et al. (2023) [37]ARHGAP15 rs6736741C12,577 cases;
9200 controls
Cases 62.5 vs. N/AUSAGWAS, RT-qPCRN/A1.17Not foundBoth sexes
Nehring et al. (2021) [28]TIMP1 rs4898T100 cases; 120 controlsMean
64.3 ± 12.4 vs. 61.8 ± 11.1
PolesRT-PCR1N/AToleratedMales
Choe et al. (2019) [17]WNT4 rs11799918
WNT4 rs75637000
WNT4 rs2473253
RHOU rs72751907
RHOU rs4993975
RHOU rs11583565
RHOU rs11580020
OAS1, OAS3 rs11066453
OAS1, OAS3 rs2072134
A
T
T
T
C
T
A
G
A
893 cases;
1075 controls

Replication:
346 cases;
305 controls
61.5 ± 5.4 vs. 54.6 ± 8.9 #KoreansGWAS;
RT-PCR
Right-sided1.39
1.366
1.415
0.657
0.676
0.676
0.672
0.694
0.676
Not found
Not found
Not found
Not found
Not found
UTR_3
UTR_3
Not found
UTR_3
Schafmayer et al. (2019) [15]
Listed only newly discovered comparing to
Maguire et al. (2018) [14]
SCAPER rs2056544
CTAGE1 rs9960286
TNRC6B rs6001870
C1TNF7 rs4132788
PIAS1 rs387505
SNX24 rs34126945
TIMP2 rs1973232
PPP1R16B rs208814
HLA-DQA1 rs7990
PLEKHA1 rs139760870
ITBP1 rs6714546
STARD13 rs14473813
G
G
C
T
T
G
G
A
A
A
A
A
UK Biobank:
31,964 cases;
419,135 controls
European replication:
3893 cases; 2829 controls
Median
72 (68–76)
vs.
68 (60–73)
European
Germans, Austrians, Lithuanians, Swedes
GWAS,
RT-PCR
N/A0.93
1.14
1.09
1.10
1.10
0.93
1.01
1.02
1.02
0.91
1.03
0.98
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Tolerated
Not found
Not found
Not found
Both sees
Reichert et al. (2018) [33]COL3A rs3134646A422 cases; 285 controlsMedian 68 (32–95) vs. 57 (19–83) #Germans, LithuaniansRT-PCRN/A1.82Not foundMales
Maguire et al. (2018) [14]ARHGAP15 rs6734367
SLC35F3 rs4333882
COLQ rs7609897
GPR1581 rs7086249
EFEMP1 rs1802575
PPP1R14A rs11667256
BDNF rs962369
FAM185A, rs6949391
LYPLAL1 rs61823192
FAM155A rs9520344,
rs11619840
SLC25A28 rs7098322
WDR70 rs10472291
ABO rs582094
COL6A1 rs75434097
LINC01082 rs2280028
P2RY12 rs9856118
DISP2 rs71472433
CRISPLD2 rs2131755
ENSG00000224849 rs4839715
UNC50 rs148376933
NOV rs1381335
S100A10 rs61814883
UBTF rs8074740
SHFM1 rs3113037
CALCA rs12293535
FADD rs875107,
rs72945112
ELN rs3823878
CWC27 rs10471645
CACNB2 rs1888693
HAS2 rs4871180
TRPS1 rs2049865
BMPR1B rs1544387
ENSG00000251283 rs11934833
HLX rs2784255
PCSK5 rs10120333
ZBTB4 rs12942267
NT5C1B rs62126581
UBL4B rs115490395
EDEM1 rs2470653
RBKS rs10173528
ISL2 rs2056544,
rs10519134
GTPBP1 rs138699
G
G
T
C
C
T
C
T
T
A
A
T
A
T
A
A
G
C
G
A

T
A
A
T
A
A
T
A
C
A
T
A
T
G
C
G
T
A
A
A
T
A
A
A
UK Biobank: 27,444 cases; 382,284 controls
MGI:
2572 cases; 28,649 controls
European
European ancestry in USA
GWAS,
RT-PCR
N/AN/ANot found
Not found
Not found
Not found
UTR_3
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Not found
Both sexes
Sigurdsson et al. (2017) [13]COLQ rs7609897
ARHGAP15 rs4662344
T
T
8734 cases; 248,971 controlsN/AIcelanders
Danes
GWAS,
RT-PCR
N/A0.87
1.23
Not found
Not found
Both sexes
* SNP’s effect according to PolyPhen2 and SIFT database; MGI—Michigan Genomics Initiative; N/A—not available; UTR—untranslated region; #—marks significant differences (p < 0.05).

3. Discussion

Colonic diverticulosis is a complex disease, with both environmental and genetic factors contributing to its pathogenesis. The role of genetic factors remodeling ECM, such as TIMP, MMP, COL, and ARHGAP, highlights the importance of collagen metabolism in the development of diverticulosis. Genetic polymorphisms in these genes may alter the balance of ECM degradation and synthesis, leading to structural changes in the colonic wall that predispose individuals to diverticula formation.
According to the results of GWAS, several candidates are identified, including blood group and immune system-related genes (ABO, HLA-DQA1, HLA-H, OAS1, TNFSF13, FADD), extracellular matrix and connective tissue genes (COL6A1, COLQ, EFEMP1, ELN, HAS2, TIMP2), signaling and cell communication (BMPR1B, WNT4, RHOU, PHGR1, PCSK5), nervous system and neurodevelopment (BDNF, CACNB2, GPR158, SIRT1, SCAPER, TRPS1), metabolism and transporters (SLC25A28, SLC35F3, RBKS, PPP1R14A, PPP1R16B), lipids and cholesterol (LDAH, LYPLAL1, STARD13), transcription and gene regulation (ZBTB4, UBTF, TNRC6B), apoptosis (FADD, PIAS1), and poorly characterized genes (C1TNF7, ENSG00000224849, ENSG00000251283, LINC01082, DISP2, SNX24, THEM4, UBL4B, UNC50, WDR70, SREK1IP1). This indicates that diverticulosis is a multifactorial disease, like alopecia, obesity, type 2 diabetes, hypercholesterolemia, and meets the criteria of a civilization disease. However, GWAS-based results are subject to certain errors of underestimation or overestimation of the population, which stem from the system of reporting diseases based on the ICD-10 and ICD-9 codes. In the worst-case scenario, data may come not from healthcare system reports but from medical interviews or patient questionnaires. It is often unclear whether a colonoscopy was performed or if only a CT scan was used. Most importantly, there is no standardized assessment of diverticulosis grading and location using available scales such as the DICA score.
Therefore, the GWAS results may be regarded as preliminary and should be confirmed in case–control or cross-sectional studies. In cross-sectional studies, only evidence of the relationship between variants of genes responsible for intestinal wall structure was found, which is consistent and expected, while the GWAS results suggest the influence of coding genes not directly related to the structure and function of the colon. Crucially, the genetics predisposing to diverticula formation may not be the same as the genetics predisposing to symptomatic uncomplicated diverticular disease or diverticulitis. Each of these conditions represents a distinct anatomopathological issue, which is not clearly differentiated in the ICD-10 and ICD-9 classifications. Furthermore, the terms “diverticulosis” and “diverticular disease” are often used interchangeably by clinicians. And for this reason, it was intended to exclude such studies because they may confound risk factors for the development of diverticula with risk factors for diverticulitis, which are shared with other infectious diseases. Asymptomatic diverticulosis represents the purest anatomical form, whereas diverticular disease can mimic and overlap with IBS symptoms, raising questions about cause-and-effect relationships. Meanwhile, diverticulitis, diagnosed based solely on abdominal CT, may be confused with complications of other conditions. Endoscopic verification and assessment using available scoring systems appear essential for a reliable diagnosis. The search for the genetic causes of diverticulitis and diverticular disease should be conducted separately from investigations into the causes of diverticula formation as anatomical changes in the colonic wall.
The search being limited to one database may be regarded as a limitation of this systematic review. Due to the heterogeneity of the studies included in this review, it lacks a mathematical analysis and synthesis of the results. The authors recognize that the limited number of studies included may result in an interpretation focused on the available results and a lack of a broader perspective.
Well-designed studies will be able to uncover the genetic determinants of diverticulosis and to explore potential therapeutic targets based on these findings.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/genes16050581/s1, Figure S1: PRISMA chart for Genetic Determinants of Colonic Diverticulosis.

Author Contributions

This study was conceptualized by A.P. Data collection was carried out by P.N. and A.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical approval was not required for this study, as it is a systematic review based on previously published data and does not involve any new data collection from human or animal participants.

Informed Consent Statement

Informed consent was not required, as this study did not involve the collection of new data from human participants.

Data Availability Statement

No novel datasets or data repositories were generated or disseminated in the course of conducting this systematic review beyond the data explicitly reported within the manuscript.

Acknowledgments

The authors would like to acknowledge Anna Oziębło, a medical student, for her support in the preparation of Figure 1.

Conflicts of Interest

The authors confirm that there are no competing interests to disclose.

References

  1. Hong, W.; Geng, W.; Wang, C.; Dong, L.; Pan, S.; Yang, X.; Zippi, M.; Xu, C.; Zhou, M.; Pan, J. Prevalence of colonic diverticulosis in mainland China from 2004 to 2014. Sci. Rep. 2016, 6, 26237. [Google Scholar] [CrossRef] [PubMed]
  2. Peery, A.F.; Keku, T.O.; Martin, C.F.; Eluri, S.; Runge, T.; Galanko, J.A.; Sandler, R.S. Distribution and Characteristics of Colonic Diverticula in a United States Screening Population. Clin. Gastroenterol. Hepatol. 2016, 14, 980–985.e981. [Google Scholar] [CrossRef]
  3. Hadrian, K.A.; Basaj, A.; Nehring, P.; Ziółkowski, B.A. Prevalence and distribution of colonic diverticulosis in patients undergoing colonoscopy. Four years’ experience from a single center in Warsaw. Arch. Med. Sci. Civiliz. Dis. 2016, 1, 30–35. [Google Scholar] [CrossRef]
  4. Burgell, R.E.; Muir, J.G.; Gibson, P.R. Pathogenesis of colonic diverticulosis: Repainting the picture. Clin. Gastroenterol. Hepatol. 2013, 11, 1628–1630. [Google Scholar] [CrossRef]
  5. Ma, W.; Jovani, M.; Nguyen, L.H.; Tabung, F.K.; Song, M.; Liu, P.H.; Cao, Y.; Tam, I.; Wu, K.; Giovannucci, E.L.; et al. Association Between Inflammatory Diets, Circulating Markers of Inflammation, and Risk of Diverticulitis. Clin. Gastroenterol. Hepatol. 2020, 18, 2279–2286.e2273. [Google Scholar] [CrossRef] [PubMed]
  6. Strate, L.L.; Keeley, B.R.; Cao, Y.; Wu, K.; Giovannucci, E.L.; Chan, A.T. Western Dietary Pattern Increases, and Prudent Dietary Pattern Decreases, Risk of Incident Diverticulitis in a Prospective Cohort Study. Gastroenterology 2017, 152, 1023–1030.e1022. [Google Scholar] [CrossRef]
  7. Strate, L.L.; Liu, Y.L.; Aldoori, W.H.; Syngal, S.; Giovannucci, E.L. Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology 2009, 136, 115–122.e111. [Google Scholar] [CrossRef]
  8. Hansen, O.; Graupe, F.; Stock, W. Prognostic factors in perforating diverticulitis of the large intestine. Chirurg 1998, 69, 443–449. [Google Scholar] [CrossRef]
  9. Baidoo, N.; Crawley, E.; Knowles, C.H.; Sanger, G.J.; Belai, A. Total collagen content and distribution is increased in human colon during advancing age. PLoS ONE 2022, 17, e0269689. [Google Scholar] [CrossRef]
  10. Mastoraki, A.; Schizas, D.; Tousia, A.; Chatzopoulos, G.; Gkiala, A.; Syllaios, A.; Frountzas, M.; Vassiliu, P.; Theodoropoulos, G.E.; Felekouras, E. Evaluation of molecular and genetic predisposing parameters at diverticular disease of the colon. Int. J. Colorectal Dis. 2021, 36, 903–910. [Google Scholar] [CrossRef]
  11. Reichert, M.C.; Lammert, F. The genetic epidemiology of diverticulosis and diverticular disease: Emerging evidence. United European Gastroenterol. J. 2015, 3, 409–418. [Google Scholar] [CrossRef] [PubMed]
  12. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef] [PubMed]
  13. Sigurdsson, S.; Alexandersson, K.F.; Sulem, P.; Feenstra, B.; Gudmundsdottir, S.; Halldorsson, G.H.; Olafsson, S.; Sigurdsson, A.; Rafnar, T.; Thorgeirsson, T.; et al. Sequence variants in ARHGAP15, COLQ and FAM155A associate with diverticular disease and diverticulitis. Nat. Commun. 2017, 8, 15789. [Google Scholar] [CrossRef] [PubMed]
  14. Maguire, L.H.; Handelman, S.K.; Du, X.; Chen, Y.; Pers, T.H.; Speliotes, E.K. Genome-wide association analyses identify 39 new susceptibility loci for diverticular disease. Nat. Genet. 2018, 50, 1359–1365. [Google Scholar] [CrossRef]
  15. Schafmayer, C.; Harrison, J.W.; Buch, S.; Lange, C.; Reichert, M.C.; Hofer, P.; Cossais, F.; Kupcinskas, J.; von Schonfels, W.; Schniewind, B.; et al. Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Gut 2019, 68, 854–865. [Google Scholar] [CrossRef]
  16. Seo, J.; Liu, H.; Young, K.; Zhang, X.; Keku, T.O.; Jones, C.D.; North, K.E.; Sandler, R.S.; Peery, A.F. Genetic and transcriptomic landscape of colonic diverticulosis. Gut 2024, 73, 932–940. [Google Scholar] [CrossRef]
  17. Choe, E.K.; Lee, J.E.; Chung, S.J.; Yang, S.Y.; Kim, Y.S.; Shin, E.S.; Choi, S.H.; Bae, J.H. Genome-wide association study of right-sided colonic diverticulosis in a Korean population. Sci. Rep. 2019, 9, 7360. [Google Scholar] [CrossRef]
  18. Choi, U.Y.; Kang, J.S.; Hwang, Y.S.; Kim, Y.J. Oligoadenylate synthase-like (OASL) proteins: Dual functions and associations with diseases. Exp. Mol. Med. 2015, 47, e144. [Google Scholar] [CrossRef]
  19. Tsaousi, A.; Williams, H.; Lyon, C.A.; Taylor, V.; Swain, A.; Johnson, J.L.; George, S.J. Wnt4/beta-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ. Res. 2011, 108, 427–436. [Google Scholar] [CrossRef]
  20. Tao, W.; Pennica, D.; Xu, L.; Kalejta, R.F.; Levine, A.J. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes. Dev. 2001, 15, 1796–1807. [Google Scholar] [CrossRef]
  21. Hu, G.; Mancl, M.E.; Barnes, B.J. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res. 2005, 65, 7403–7412. [Google Scholar] [CrossRef]
  22. Vavricka, S.R.; Brun, L.; Ballabeni, P.; Pittet, V.; Prinz Vavricka, B.M.; Zeitz, J.; Rogler, G.; Schoepfer, A.M. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am. J. Gastroenterol. 2011, 106, 110–119. [Google Scholar] [CrossRef] [PubMed]
  23. Altadill, A.; Eiró, N.; González, L.O.; Junquera, S.; González-Quintana, J.M.; Sánchez, M.R.; Andicoechea, A.; Saro, C.; Rodrigo, L.; Vizoso, F.J. Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn’s disease and complicated diverticular disease. Inflamm. Bowel Dis. 2012, 18, 120–130. [Google Scholar] [CrossRef] [PubMed]
  24. Mimura, T.; Bateman, A.C.; Lee, R.L.; Johnson, P.A.; McDonald, P.J.; Talbot, I.C.; Kamm, M.A.; MacDonald, T.T.; Pender, S.L. Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease. Dis. Colon. Rectum 2004, 47, 371–378, discussion 378–379. [Google Scholar] [CrossRef] [PubMed]
  25. Ghomi Tabatabaee, F.A.; Vasudevan, R.; Heidari, F.; Khazaei, S.; Etemad, A.; Ismail, P. Association of MMP-1, 9, 12 and TIMP-1 gene polymorphisms in Malaysian male hypertensive subjects. Biomed. Res. 2018, 29, 1734–1742. [Google Scholar] [CrossRef]
  26. Meijer, M.J.; Mieremet-Ooms, M.A.; van Hogezand, R.A.; Lamers, C.B.; Hommes, D.W.; Verspaget, H.W. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J. Gastroenterol. 2007, 13, 2960–2966. [Google Scholar] [CrossRef]
  27. Lorente, L.; Martin, M.M.; Sole-Violan, J.; Blanquer, J.; Labarta, L.; Diaz, C.; Borreguero-Leon, J.M.; Orbe, J.; Rodriguez, J.A.; Jimenez, A.; et al. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PLoS ONE 2014, 9, e94318. [Google Scholar] [CrossRef]
  28. Nehring, P.; Gromadzka, G.; Giermaziak, A.; Jastrzebski, M.; Przybylkowski, A. Genetic variants of tissue inhibitors of matrix metalloproteinase 1 (rs4898) and 2 (rs8179090) in diverticulosis. Eur. J. Gastroenterol. Hepatol. 2021, 33, e431–e434. [Google Scholar] [CrossRef]
  29. Nehring, P.; Gromadzka, G.; Jastrzebski, M.; Przybylkowski, A. Genetic Variants in Matrix Metalloproteinases MMP3 (rs3025058) and MMP9 (rs3918242) Associated with Colonic Diverticulosis. Medicina 2023, 59, 2031. [Google Scholar] [CrossRef]
  30. Ries, C. Cytokine functions of TIMP-1. Cell Mol. Life Sci. 2014, 71, 659–672. [Google Scholar] [CrossRef]
  31. Ram, M.; Sherer, Y.; Shoenfeld, Y. Matrix metalloproteinase-9 and autoimmune diseases. J. Clin. Immunol. 2006, 26, 299–307. [Google Scholar] [CrossRef]
  32. Rosemar, A.; Ivarsson, M.L.; Borjesson, L.; Holmdahl, L. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Scand. J. Gastroenterol. 2007, 42, 215–220. [Google Scholar] [CrossRef]
  33. Reichert, M.C.; Kupcinskas, J.; Krawczyk, M.; Jungst, C.; Casper, M.; Grunhage, F.; Appenrodt, B.; Zimmer, V.; Weber, S.N.; Tamelis, A.; et al. A Variant of COL3A1 (rs3134646) Is Associated With Risk of Developing Diverticulosis in White Men. Dis. Colon. Rectum 2018, 61, 604–611. [Google Scholar] [CrossRef] [PubMed]
  34. Asling, B.; Jirholt, J.; Hammond, P.; Knutsson, M.; Walentinsson, A.; Davidson, G.; Agreus, L.; Lehmann, A.; Lagerstrom-Fermer, M. Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia. Gut 2009, 58, 1063–1069. [Google Scholar] [CrossRef]
  35. Nehring, P.; Placha, G.; Przybylkowski, A. Collagen (rs3134646) and AGHRP (rs4662344) genetic variants may predispose to colonic diverticulosis. Adv. Med. Sci. 2025, 70, 231–236. [Google Scholar] [CrossRef] [PubMed]
  36. Bode, M.K.; Karttunen, T.J.; Makela, J.; Risteli, L.; Risteli, J. Type I and III collagens in human colon cancer and diverticulosis. Scand. J. Gastroenterol. 2000, 35, 747–752. [Google Scholar] [CrossRef] [PubMed]
  37. Joo, Y.Y.; Pacheco, J.A.; Thompson, W.K.; Rasmussen-Torvik, L.J.; Rasmussen, L.V.; Lin, F.T.J.; Andrade, M.; Borthwick, K.M.; Bottinger, E.; Cagan, A.; et al. Multi-ancestry genome- and phenome-wide association studies of diverticular disease in electronic health records with natural language processing enriched phenotyping algorithm. PLoS ONE 2023, 18, e0283553. [Google Scholar] [CrossRef]
  38. Seoh, M.L.; Ng, C.H.; Yong, J.; Lim, L.; Leung, T. ArhGAP15, a novel human RacGAP protein with GTPase binding property. FEBS Lett. 2003, 539, 131–137. [Google Scholar] [CrossRef]
  39. Kline, B.P.; Yochum, G.S.; Brinton, D.L.; Schieffer, K.M.; Weaver, T.; Harris, L.; Deiling, S.; Berg, A.S.; Koltun, W.A. COLQ and ARHGAP15 are Associated with Diverticular Disease and are Expressed in the Colon. J. Surg. Res. 2021, 267, 397–403. [Google Scholar] [CrossRef]
  40. Carter, K.W.; Hung, J.; Powell, B.L.; Wiltshire, S.; Foo, B.T.; Leow, Y.C.; McQuillan, B.M.; Jennens, M.; McCaskie, P.A.; Thompson, P.L.; et al. Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population. Hum. Genet. 2008, 124, 199–206. [Google Scholar] [CrossRef]
  41. Virtanen, I.M.; Karppinen, J.; Taimela, S.; Ott, J.; Barral, S.; Kaikkonen, K.; Heikkila, O.; Mutanen, P.; Noponen, N.; Mannikko, M.; et al. Occupational and genetic risk factors associated with intervertebral disc disease. Spine 2007, 32, 1129–1134. [Google Scholar] [CrossRef] [PubMed]
  42. Connelly, T.M.; Berg, A.S.; Hegarty, J.P.; Deiling, S.; Brinton, D.; Poritz, L.S.; Koltun, W.A. The TNFSF15 gene single nucleotide polymorphism rs7848647 is associated with surgical diverticulitis. Ann. Surg. 2014, 259, 1132–1137. [Google Scholar] [CrossRef] [PubMed]
  43. Zhang, J.; Zhang, J.; Wu, D.; Wang, J.; Dong, W. Associations between TNFSF15 polymorphisms and susceptibility to ulcerative colitis and Crohn’s disease: A meta-analysis. Autoimmunity 2014, 47, 512–518. [Google Scholar] [CrossRef]
  44. Yang, S.K.; Lim, J.; Chang, H.S.; Lee, I.; Li, Y.; Liu, J.; Song, K. Association of TNFSF15 with Crohn’s disease in Koreans. Am. J. Gastroenterol. 2008, 103, 1437–1442. [Google Scholar] [CrossRef] [PubMed]
  45. Swan, C.; Duroudier, N.P.; Campbell, E.; Zaitoun, A.; Hastings, M.; Dukes, G.E.; Cox, J.; Kelly, F.M.; Wilde, J.; Lennon, M.G.; et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): Association with TNFSF15 and TNFalpha. Gut 2013, 62, 985–994. [Google Scholar] [CrossRef]
  46. Michelsen, K.S.; Thomas, L.S.; Taylor, K.D.; Yu, Q.T.; Mei, L.; Landers, C.J.; Derkowski, C.; McGovern, D.P.; Rotter, J.I.; Targan, S.R. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS ONE 2009, 4, e4719. [Google Scholar] [CrossRef]
Figure 1. Overview of genetic determinants in colonic diverticulosis and proposed disease progression. Figure 1 demonstrates progression stages of diverticulosis from normal wall of large intestine (stage 0) to weakening of tissue in site of vasa recta passing muscular layer (stage 1) and full diverticula formation (stage 2). The left side of the figure groups genes identified in GWAS studies and the right side groups genes identified in SNP studies, according to possible mechanisms. Diverticulitis may complicate diverticulosis in carriers of predisposing proinflammatory genes.
Figure 1. Overview of genetic determinants in colonic diverticulosis and proposed disease progression. Figure 1 demonstrates progression stages of diverticulosis from normal wall of large intestine (stage 0) to weakening of tissue in site of vasa recta passing muscular layer (stage 1) and full diverticula formation (stage 2). The left side of the figure groups genes identified in GWAS studies and the right side groups genes identified in SNP studies, according to possible mechanisms. Diverticulitis may complicate diverticulosis in carriers of predisposing proinflammatory genes.
Genes 16 00581 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nehring, P.; Przybyłkowski, A. Genetic Determinants of Colonic Diverticulosis—A Systematic Review. Genes 2025, 16, 581. https://doi.org/10.3390/genes16050581

AMA Style

Nehring P, Przybyłkowski A. Genetic Determinants of Colonic Diverticulosis—A Systematic Review. Genes. 2025; 16(5):581. https://doi.org/10.3390/genes16050581

Chicago/Turabian Style

Nehring, Piotr, and Adam Przybyłkowski. 2025. "Genetic Determinants of Colonic Diverticulosis—A Systematic Review" Genes 16, no. 5: 581. https://doi.org/10.3390/genes16050581

APA Style

Nehring, P., & Przybyłkowski, A. (2025). Genetic Determinants of Colonic Diverticulosis—A Systematic Review. Genes, 16(5), 581. https://doi.org/10.3390/genes16050581

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop